Spiration® News and Information
Recent Company Announcements
- Spiration, Inc. Presents Further Analysis of Computed Tomography Results from Pilot Study of Innovative Treatment for Emphysema
Toronto and Redmond, Wash. | May 20, 2008 | Spiration, Inc., a developer of novel medical devices designed to benefit patients with severe and chronic conditions of the lung, today presented further results of a Computed Tomography (CT) Study at the Annual American Thoracic Society (ATS) International conference taking place in Toronto May 16 to 21, 2008.
(pdf, 25k)
- Olympus Medical Systems Corp. and Spiration, Inc. Sign Agreement to Market and Distribute Minimally Invasive Pulmonary Device in 43 European Countries
Tokyo and Redmond, Wash. | May 19, 2008 | Olympus Medical Systems Corp. and Spiration, Inc. announced today that the companies have signed a definitive agreement granting Olympus exclusive marketing and distribution rights in Europe for Spiration’s IBV® Valve System. Olympus will launch the product in select European countries in late 2008. (pdf, 23k)
- Spiration, Inc. Raises $18.5 Million Equity Financing
Redmond, Wash. | March 25, 2008 | Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, announced today that the company has raised $18.5 million in a series G round of equity funding from existing investors. (pdf, 24k)
- Spiration, Inc. Presents Emphysema Device Removal Data at American College of Chest Physicians Annual Conference in Chicago
Chicago | Oct. 24, 2007 | A presentation at the American College of Chest Physicians Annual Conference in Chicago today concludes that bronchial valves designed and manufactured by Spiration® for the treatment of patients with severe emphysema can be successfully removed with a high success rate during a minimally invasive bronchoscopic procedure. (pdf, 24k)
- Spiration, Inc. Announces First Patient Enrollment in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
Redmond, Wash. | Sept. 26, 2007 | Spiration, Inc., a developer of novel medical technology
designed to benefit patients with acute and chronic conditions of the lung, today announced that
the first patients have been enrolled in the company’s IBV Valve Trial in the United States. (pdf, 24k)
- Spiration, Inc. Announces Positive Results from Pilot Study of Treatment for Patients with Severe Emphysema at European Respiratory Society’s Annual Congress
Redmond, Wash. and Stockholm | September 19, 2007 | Spiration, Inc., a developer of novel medical technology designed to benefit patients with acute and chronic conditions of the lung, today reported further results of a pilot study of its IBV Valve System for patients with severe emphysema. (pdf, 27k)
- Spiration, Inc. Names Nancy Hill Vice President, Marketing to Strengthen Market Development and Global Product Commercialization Initiatives
REDMOND, Wash. | MAY 29, 2007 | Spiration, Inc., a developer of novel medical technology designed to benefit patients with severe and chronic conditions of the lung, announced today the appointment of Nancy Hill as Vice President of Marketing.
(pdf, 50mb)
- New Way to Use High Resolution CT Scan Shows Mechanism of Bronchial Valve Treatment in Patients with Emphysema
San Francisco | MAY 23, 2007 | Results of a Computed Tomography (CT) Study presented today at the Annual American Thoracic Society (ATS) 2007 International meeting, elucidate the novel mechanism of action of bronchial valve treatment.
(pdf, 31k)
Spiration in the News
- CHEST 2006 - "Umbrella" Valve Provides a Potential Alternative to Lung Surgery
Salt Lake City, UT | October 23, 2006 | A new umbrella-like valve may help patients with emphysema breathe easier and may ultimately provide a noninvasive alternative to lung reduction surgery.
Fact Sheets
- Company Fact Sheet (pdf, 70k)
- US IBV Valve Trial Fact Sheet (pdf, 19.5k)
- IBV Valve System Fact Sheet (pdf, 31k)
Animation
- IBV Valve System Animation (zip, 95mb)
Media Contact
For media inquires or company b-roll, please contact:
Nicole Osmer
650-454-0504
nicole@nicoleosmer.com